BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2315912)

  • 1. Pharmacokinetics of benzene.
    Travis CC; Quillen JL; Arms AD
    Toxicol Appl Pharmacol; 1990 Mar; 102(3):400-20. PubMed ID: 2315912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of tetrachloroethylene.
    Ward RC; Travis CC; Hetrick DM; Andersen ME; Gargas ML
    Toxicol Appl Pharmacol; 1988 Mar; 93(1):108-17. PubMed ID: 3353997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of exposure rate effects for benzene using a physiologically based pharmacokinetic model.
    Bois FY; Paxman DG
    Regul Toxicol Pharmacol; 1992 Apr; 15(2 Pt 1):122-36. PubMed ID: 1626064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzene toxicokinetics in humans: exposure of bone marrow to metabolites.
    Watanabe KH; Bois FY; Daisey JM; Auslander DM; Spear RC
    Occup Environ Med; 1994 Jun; 51(6):414-20. PubMed ID: 8044234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interspecies extrapolation of physiological pharmacokinetic parameter distributions.
    Watanabe KH; Bois FY
    Risk Anal; 1996 Dec; 16(6):741-54. PubMed ID: 8972106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population toxicokinetics of benzene.
    Bois FY; Jackson ET; Pekari K; Smith MT
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1405-11. PubMed ID: 9118927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
    Cox LA
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice.
    Sabourin PJ; Bechtold WE; Griffith WC; Birnbaum LS; Lucier G; Henderson RF
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):421-44. PubMed ID: 2749731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of benzene carcinogenesis: application of a physiological model of benzene pharmacokinetics and metabolism.
    Bois FY; Smith MT; Spear RC
    Toxicol Lett; 1991 May; 56(3):283-98. PubMed ID: 2035176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzene increases protein-bound 3-nitrotyrosine in bone marrow of B6C3F1 mice.
    Chen KM; El-Bayoumy K; Hosey J; Cunningham J; Aliaga C; Melikian AA
    Chem Biol Interact; 2005 Oct; 156(2-3):81-91. PubMed ID: 16139254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice.
    Sabourin PJ; Bechtold WE; Birnbaum LS; Lucier G; Henderson RF
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):128-40. PubMed ID: 3376110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-specific metabolism in mouse bone marrow stroma: studies of activation and detoxification of benzene metabolites.
    Ganousis LG; Goon D; Zyglewska T; Wu KK; Ross D
    Mol Pharmacol; 1992 Dec; 42(6):1118-25. PubMed ID: 1480134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the DNA adducts formed in B6C3F1 mice treated with benzene: implications for molecular dosimetry.
    Bodell WJ; Pathak DN; LĂ©vay G; Ye Q; Pongracz K
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1189-93. PubMed ID: 9118892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implications.
    Spear RC; Bois FY; Woodruff T; Auslander D; Parker J; Selvin S
    Risk Anal; 1991 Dec; 11(4):641-54. PubMed ID: 1780503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species and strain comparisons in the macromolecular binding of extremely low doses of [14C]benzene in rodents, using accelerator mass spectrometry.
    Mani C; Freeman S; Nelson DO; Vogel JS; Turteltaub KW
    Toxicol Appl Pharmacol; 1999 Sep; 159(2):83-90. PubMed ID: 10495771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the pathways for metabolism of benzene in rats and mice simulated by a physiological model.
    Medinsky MA; Sabourin PJ; Henderson RF; Lucier G; Birnbaum LS
    Environ Health Perspect; 1989 Jul; 82():43-9. PubMed ID: 2792050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Compartment simulation models and physiologic use in pharmaco- and toxicokinetics].
    Kostrzewski P
    Med Pr; 1998; 49(1):83-92. PubMed ID: 9587914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute cytogenetic effect of benzene on rat bone marrow cells in vivo and the effect of inducers or inhibitors of drug-metabolizing enzymes.
    Fujie K; Ito Y; Maeda S
    Mutat Res; 1992 Dec; 298(2):81-90. PubMed ID: 1282215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of exposure regimen and duration on benzene-induced bone marrow damage in mice. II. Strain comparisons involving B6C3F1, C57B1/6 and DBA/2 male mice.
    Luke CA; Tice RR; Drew RT
    Mutat Res; 1988 Aug; 203(4):273-95. PubMed ID: 3405236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A physiological model for simulation of benzene metabolism by rats and mice.
    Medinsky MA; Sabourin PJ; Lucier G; Birnbaum LS; Henderson RF
    Toxicol Appl Pharmacol; 1989 Jun; 99(2):193-206. PubMed ID: 2734786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.